Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin

Terminated

Conditions: Pulmonary Arterial Hypertension

Interventions: Drug: Sitaxentan sodium

First Posted Date: 2009-10-15

Last Posted Date: 2012-02-07

Lead Sponsor: Pfizer

Target Recruit Count: 54

Registration Number: NCT00995566

Locations: 🇩🇪
Pfizer Investigational Site, Hannover, Germany

A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections

Phase 2

Terminated

Conditions: Osteoarthritis, Knee
Osteoarthritis, Hip

Interventions: Drug: Tanezumab 5 mg
Drug: Tanezumab 10 mg
Drug: Tanezumab 2.5 mg

First Posted Date: 2009-10-14

Last Posted Date: 2021-05-13

Lead Sponsor: Pfizer

Target Recruit Count: 679

Registration Number: NCT00994890

Locations: 🇺🇸
Mobile Diagnostic Center, Mobile, Alabama, United States
🇺🇸
Seton Medical Management, Inc., Mobile, Alabama, United States
🇺🇸
Phoenix Rheumatology Specialists, Ltd., Phoenix, Arizona, United States

and more 90 locations

To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04531083 In Healthy Male Subjects

Completed

Conditions: Pain

Interventions: Drug: PF-04531083

First Posted Date: 2009-10-09

Last Posted Date: 2009-12-17

Lead Sponsor: Pfizer

Target Recruit Count: 80

Registration Number: NCT00992316

Locations: 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium

Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept

Phase 4

Completed

Conditions: Psoriasis

Interventions: Drug: etanercept

First Posted Date: 2009-10-09

Last Posted Date: 2016-01-08

Lead Sponsor: Pfizer

Target Recruit Count: 174

Registration Number: NCT00992394

Locations: 🇫🇷
Centre Hopitalier St Jacques (Place St Jacques), Besancon, France
🇫🇷
CHU Dupuytren, Limoges, France
🇫🇷
Service de Chirurgie Infantile, Lyon Cedex 03, France

and more 42 locations

A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-03893787

First Posted Date: 2009-10-09

Last Posted Date: 2010-03-18

Lead Sponsor: Pfizer

Target Recruit Count: 36

Registration Number: NCT00992342

Locations: 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium

A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin

Phase 1

Completed

Conditions: Alzheimer's Disease
Huntington's Disease

Interventions: Drug: Dimebon IR
Drug: Dimebon Transdermal

First Posted Date: 2009-10-07

Last Posted Date: 2010-02-03

Lead Sponsor: Pfizer

Target Recruit Count: 19

Registration Number: NCT00990613

Locations: 🇺🇸
Pfizer Investigational Site, Kalamazoo, Michigan, United States

A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03526299 In Healthy Adult Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-03526299

First Posted Date: 2009-10-07

Last Posted Date: 2010-01-22

Lead Sponsor: Pfizer

Target Recruit Count: 24

Registration Number: NCT00990756

Locations: 🇸🇬
Pfizer Investigational Site, Singapore, Singapore

A Study To Access The Safety And Tolerability Of RN316 (PF-04950615) When Administered To Healthy Adult Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Biological: RN316

First Posted Date: 2009-10-07

Last Posted Date: 2012-07-04

Lead Sponsor: Pfizer

Target Recruit Count: 48

Registration Number: NCT00991159

Locations: 🇺🇸
Pfizer Investigational Site, Miami Gardens, Florida, United States

Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers

Phase 1

Terminated

Conditions: Healthy Volunteers

Interventions: Drug: PF-04805712

First Posted Date: 2009-10-07

Last Posted Date: 2010-11-24

Lead Sponsor: Pfizer

Target Recruit Count: 61

Registration Number: NCT00991016

Locations: 🇸🇬
Pfizer Investigational Site, Singapore, Singapore

A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: PF-04308515
Drug: Placebo

First Posted Date: 2009-10-06

Last Posted Date: 2010-02-01

Lead Sponsor: Pfizer

Target Recruit Count: 27

Registration Number: NCT00990015

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy